HLA-DPB1 mismatches and classification as permissive or nonpermissive in UD-recipient pairs from this study
. | . | HLA-DPB1‡ . | . | |
---|---|---|---|---|
Classification* and UPN . | Outcome† . | Recipient . | Donor . | |
Permissive (n = 24) | ||||
1 | — | 0201 | 0201,0401 | |
2 | — | 0201,0402 | 0201,0401 | |
3 | — | 0401 | 0101,0401 | |
4 | — | 0401,1101 | 0401,0402 | |
5 | — | 0401 | 0401,0402 | |
6 | R | 0201,0401 | 0401 | |
7 | R | 0401 | 0201,0401 | |
8 | III | 0301,1701 | 0401,1701 | |
9 | — | 0201,0402 | 0402,1101 | |
10 | — | 0201,0401 | 0401 | |
11 | — | 0201,0402 | 0201,0401 | |
12 | — | 0301,0402 | 0301,0401 | |
13 | II | 0201,0301 | 0301,0401 | |
14 | — | 0401 | 0401,0402 | |
15 | II | 0201 | 0401 | |
16 | — | 0402 | 0202,0401 | |
17 | — | 0401 | 0201 | |
18 | — | 0201 | 0401,0402 | |
19 | — | 1401 | 0301 | |
20 | — | 0101 | 0101,0401 | |
21 | — | 0402,1601 | 0201,0401 | |
22 | — | 0401,0402 | 0201,0401 | |
23 | II | 0402 | 0402,1101 | |
24 | II | 0301,0401 | 0201,0301 | |
Nonpermissive HvG (n = 17) | ||||
25 | II | 0401,2401§ | 0301,0401 | |
26 | R | 0201,0401 | 0201,0301 | |
27 | II | 0401 | 00301,0401 | |
28 | II | 0201,0401 | 0301,0401 | |
29 | — | 0401,0402 | 0301,0402 | |
30 | — | 0201,0401 | 0301,0401 | |
31 | — | 0401,0402 | 0401,1001 | |
32 | II | 0201 | 0301,0402 | |
33 | IV | 0201 | 0301,0401 | |
34 | R | 0401,0402 | 0201,0301 | |
35 | R | 0201,1501 | 0401,1401 | |
36 | II, R | 0401 | 0301,1301 | |
37 | — | 0401,0601 | 1001,2301 | |
38 | — | 0301,0401 | 1001 | |
39 | — | 0201 | 0301,0401 | |
40 | II | 0201,0401 | 0301,1701 | |
41 | IV | 0201 | 0301,0401 | |
Nonpermissive GvH (n = 10) | ||||
42 | R | 0401,1001 | 0301,0401 | |
43 | — | 0201,0301 | 0201 | |
44 | III | 0401,1001 | 0401,0501 | |
45 | — | 0301,0401 | 0401,0402 | |
46 | — | 1101,1701 | 0101,1101 | |
47 | — | 0301,1701 | 0401,0402 | |
48 | III | 1001 | 0301,1601 | |
49 | III | 0301,0402 | 0401 | |
50 | — | 0301,0401 | 0401 | |
51 | II | 0401,1001 | 0402,2001 |
. | . | HLA-DPB1‡ . | . | |
---|---|---|---|---|
Classification* and UPN . | Outcome† . | Recipient . | Donor . | |
Permissive (n = 24) | ||||
1 | — | 0201 | 0201,0401 | |
2 | — | 0201,0402 | 0201,0401 | |
3 | — | 0401 | 0101,0401 | |
4 | — | 0401,1101 | 0401,0402 | |
5 | — | 0401 | 0401,0402 | |
6 | R | 0201,0401 | 0401 | |
7 | R | 0401 | 0201,0401 | |
8 | III | 0301,1701 | 0401,1701 | |
9 | — | 0201,0402 | 0402,1101 | |
10 | — | 0201,0401 | 0401 | |
11 | — | 0201,0402 | 0201,0401 | |
12 | — | 0301,0402 | 0301,0401 | |
13 | II | 0201,0301 | 0301,0401 | |
14 | — | 0401 | 0401,0402 | |
15 | II | 0201 | 0401 | |
16 | — | 0402 | 0202,0401 | |
17 | — | 0401 | 0201 | |
18 | — | 0201 | 0401,0402 | |
19 | — | 1401 | 0301 | |
20 | — | 0101 | 0101,0401 | |
21 | — | 0402,1601 | 0201,0401 | |
22 | — | 0401,0402 | 0201,0401 | |
23 | II | 0402 | 0402,1101 | |
24 | II | 0301,0401 | 0201,0301 | |
Nonpermissive HvG (n = 17) | ||||
25 | II | 0401,2401§ | 0301,0401 | |
26 | R | 0201,0401 | 0201,0301 | |
27 | II | 0401 | 00301,0401 | |
28 | II | 0201,0401 | 0301,0401 | |
29 | — | 0401,0402 | 0301,0402 | |
30 | — | 0201,0401 | 0301,0401 | |
31 | — | 0401,0402 | 0401,1001 | |
32 | II | 0201 | 0301,0402 | |
33 | IV | 0201 | 0301,0401 | |
34 | R | 0401,0402 | 0201,0301 | |
35 | R | 0201,1501 | 0401,1401 | |
36 | II, R | 0401 | 0301,1301 | |
37 | — | 0401,0601 | 1001,2301 | |
38 | — | 0301,0401 | 1001 | |
39 | — | 0201 | 0301,0401 | |
40 | II | 0201,0401 | 0301,1701 | |
41 | IV | 0201 | 0301,0401 | |
Nonpermissive GvH (n = 10) | ||||
42 | R | 0401,1001 | 0301,0401 | |
43 | — | 0201,0301 | 0201 | |
44 | III | 0401,1001 | 0401,0501 | |
45 | — | 0301,0401 | 0401,0402 | |
46 | — | 1101,1701 | 0101,1101 | |
47 | — | 0301,1701 | 0401,0402 | |
48 | III | 1001 | 0301,1601 | |
49 | III | 0301,0402 | 0401 | |
50 | — | 0301,0401 | 0401 | |
51 | II | 0401,1001 | 0402,2001 |
UPN indicates unique patient number; —, neither GVHD nor rejection.
Classification of HLA-DPB1 mismatches as permissive or nonpermissive in HvG or GvH direction, according to the algorithm we previously described13
Outcome of each patient receiving a transplant in terms of occurrence of graft rejection (R) or acute GvHD grade II (II), III (III), or IV (IV), defined according to the criteria stated in “Patients and methods”
Complete typing of HLA-DPB1 alleles present in the recipient and in the donor. Immunogenicity groups of HLA-DPB1 alleles according to the algorithm we previously described13 are indicated as follows: group 1, highly immunogenic (underlining); group 2, intermediately immunogenic (italics); group 3, poorly immunogenic (normal typeface)
HLA-DPB1*2401 was assigned to group 3 of nonimmunogenic alleles on the basis of amino acid sequence homology with DPB1*4601, the prototype of group 3 alleles, and not as all other alleles, on the basis of functional studies using alloreactive T lymphocytes13